The Journal of Arthroplasty in August published data showing local infiltration analgesia (LIA) with liposomal bupivacaine (LB) made by Parsippany, NJ-based Pacira Pharmaceuticals improves pain scores and reduces opioid use after total knee arthroplasty (TKA) compared with LIA alone.
Read More:
Pacira’s Exparel cuts post-TKA opioid use